Stockscreener 앱 받기
3.88
3.00%
-0.12
시간 외 거래:
3.84
-0.04
-1.03%
전일 마감가:
$4.00
열려 있는:
$3.99
하루 거래량:
367.58K
Relative Volume:
0.52
시가총액:
$492.21M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
108.68
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-7.40%
1개월 성능:
-9.56%
6개월 성능:
-26.52%
1년 성능:
+29.77%
1일 변동 폭
$3.84
$4.07
1주일 범위
$3.84
$4.39
52주 변동 폭
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.88 | 507.43M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Why Organogenesis Holdings Inc. stock could be next big winner2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Organogenesis (NASDAQ:ORGO) Director Sells $66,287.20 in Stock - MarketBeat
Glenn Nussdorf Sells 4,156 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Purchases 251,001 Shares of Stock - MarketBeat
Glenn Nussdorf Buys 107,494 Shares of Organogenesis (NASDAQ:ORGO) Stock - MarketBeat
Is Organogenesis Holdings Inc. showing signs of accumulation2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
What indicators show strength in Organogenesis Holdings Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Multi asset correlation models including Organogenesis Holdings Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com
Exit strategy if you’re trapped in Organogenesis Holdings Inc.July 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com
Will Organogenesis Holdings Inc. stock maintain momentum in 2025 - newser.com
Has Organogenesis Holdings Inc. formed a bullish divergenceJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
Why pension funds invest in Organogenesis Holdings Inc. (2PQ) stockJuly 2025 Gainers & Safe Capital Growth Stock Tips - newser.com
What to expect from Organogenesis Holdings Inc. in the next 30 daysJuly 2025 Action & AI Enhanced Trading Signals - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategiesTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Organogenesis Applauds CMS’s Significant Step In Payment Reform - The Manila Times
Organogenesis Holdings Inc. Commends CMS on Payment Reform for Skin Substitutes and CTPs Under CY 2026 Fee Schedule - Quiver Quantitative
Organogenesis (Nasdaq: ORGO) applauds CMS 2026: per‑cm payments, FDA classifications finalized - Stock Titan
Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Asia Pacific Wound Care Biologics Market Growth in Future Scope - openPR.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025July 2025 Setups & High Accuracy Investment Signals - newser.com
Will Organogenesis Holdings Inc. outperform the marketJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Real time pattern detection on Organogenesis Holdings Inc. stockJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Volume Report & Weekly Market Pulse Updates - newser.com
Why Organogenesis Holdings Inc. (2PQ) stock stays on top picksWeekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organogenesis Holdings Inc. (ORGO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Why Organogenesis Holdings Inc. stock is trending among retail tradersBond Market & Long-Term Growth Plans - newser.com
Can Organogenesis Holdings Inc. rally from current levelsWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Organogenesis (NASDAQ: ORGO) awards CTO inducement equity at $4.17, 4-year vesting - Stock Titan
Organogenesis Holdings Inc. (ORGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Top chart patterns to watch in Organogenesis Holdings Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Published on: 2025-10-31 05:50:02 - newser.com
Published on: 2025-10-31 03:32:15 - newser.com
What high frequency data says about Organogenesis Holdings Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.60%
0.45%
자본화:
|
볼륨(24시간):